2,4,6-Tris(p-aminoanilino)-1,3,5-triazine: Synthesis and Electron Paramagnetic Resonance (EPR) Analysis
-
Published:2022-10-10
Issue:
Volume:
Page:
-
ISSN:1301-4048
-
Container-title:Sakarya University Journal of Science
-
language:en
-
Short-container-title:SAUJS
Author:
KARATAŞ Özgül1ORCID, CEYLAN Yusuf2ORCID, KOÇ Ziya Erdem3
Affiliation:
1. Konya Teknik Üniversitesi 2. SELÇUK ÜNİVERSİTESİ 3. SELCUK UNIVERSITY
Abstract
A significant group of compounds arise from substituted s-triazine derivatives that have tripodal heterocyclic compound. Compounds classified as heterocyclic possible created the largest and most diverse family of organic compounds. In this study, we reported that a new template has been syntheses from a cyanuric chloride and its diamine derivative. The desired triamine a tripodal 2, 4, 6-tris (p-aminoaanilino)-1, 3, 5-triazine (C21H21N9), called to be TRIPOD, has been obtained from cyanuric chloride with 3 eq of p-phenylenediamine reaction in acetone. After synthesis, TRIPOD sample which was polycrystal form was irradiated by cobalt-gamma source. The electron paramagnetic resonance spectra of TRIPOD were recorded using X-band EPR spectrometer at room temperature in three axes (x, y, z) which are perpendicular at 10 intervals. The EPR spectrum was simulated using computer program and by using the spectrum. The radical structure was determined in the sample.
Publisher
Sakarya University Journal of Science
Reference47 articles.
1. [1] S. Singh, M. K. Mandal, A. Masih, A. Saha, S. K. Ghosh, H. R. Bhat, U. P. Singh, “1,3,5-Triazine: A versatile pharmacophore with diverse biological activities”, Archiv der Pharmazie, vol. 354, no. 6, pp. 1-23, 2021. 2. [2] D. Maliszewski, A. Wrobel, B. Kolensinska, J. Fraczyk, D. Drozdowska, “1,3,5-Triazine Nitrogen Mustards with Different Peptide Group as Innovative Candidates for AChE and BACE1 Inhibitors”, Molecules, vol. 26, pp. 3942, 2021. 3. [3] F. Li, C. Wang, Y. Xu, Z. Zhao, J. Su, C. Luo, Y. Ning, Z. Li, C. Li, L. Wang, “Efficient synthesis of unsymmetrical trisubstituted 1,3,5-triazines catalyzed by hemoglobin”, Molecular Catalysis, vol. 505, pp. 111519, 2021. 4. [4] K. Kaminska, J. Ziemb, J. Ner, J. S. Schwed, D. Łazewska, M. Wiecek, T. Karcz, A. Olejarz, G. Latacz, K. Kuder, T. Kottke, M. Zygmunt, J. Sapa, J. K. Wojciechowska, H. Stark, K. K.-Kononowicz, K., “(2-Arylethenyl)-1,3,5-triazin-2-amines as novel histamine H4 receptor ligands”, European Journal of Medicinal Chemistry, vol. 103, pp. 238–251, 2015. 5. [5] W. Huang, W. Zheng, D. J. Urban, J. Inglese, E. Sidransky, C. P. Austin, C. J., Thomas, “N4-phenyl modifications of N2-(2-hydroxyl) ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease”, Bioorganic & Medicinal Chemistry Letters, vol. 17, pp. 5783–5789, 2007.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|